False Advertising · Final Approval Granted

$19.16M Joint Juice New York Settlement

Published February 3, 2026
Updated July 29, 2026

The Joint Juice New York settlement resolves false-advertising claims over glucosamine supplements; final approval was granted, but payments await appeal resolution.

$19.16M Joint Juice New York Settlement

Current Status

The court granted final approval on May 14, 2026. The official FAQ says cash payments will not be issued until any appeals are resolved, which may take substantial time. The May 18 claim deadline has passed.

StatusFinal Approval Granted — Appeals May Delay Payments
Claim DeadlineMay 18, 2026 (Passed)
BenefitApproximately $50 per qualifying unit, subject to adjustment
Proof RequiredNo receipts for up to six units; documentation for additional units

What Is This Case About?

The case alleged that Premier Nutrition made misleading claims about the joint-health benefits of Joint Juice glucosamine products. Premier Nutrition disputed the claims, and the parties settled after a judgment and continuing appellate litigation.

Who Was Included?

The settlement covered qualifying purchases of Joint Juice products in New York from December 5, 2013 through December 28, 2021. Some members identified through retailer records qualified for automatic direct payments.

What Was the Benefit?

The official FAQ estimates approximately $50 per eligible unit. Claims without receipts were allowed for up to six units, while documentation could support additional purchases. Final awards may be adjusted based on claims and the settlement terms.

Official Information

Review the latest administrator notices and documents on the official Joint Juice New York Settlement.

Settlement Amount $19,160,186.47
Case Title Montera v. Premier Nutrition Corporation
Case Number 3:16-cv-06980-RS
Court U.S. District Court, Northern District of California
Final Approval Hearing Final approval granted May 14, 2026
For more class actions, recalls, and refunds, keep scrolling below.

More Consumer Settlements